Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent C Luca

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal for Immunotherapy of Cancer|August 18, 2025
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma modelsManali S Phadke, Jiannong Li, Sathya Sriramareddy, et al.
Structure (London, England : 1993)|February 26, 2026
Structural basis for sialoglycan recognition by the immune inhibitory receptor Siglec-10Elliot Medina, Charlotte Mason, Timothy H Tran, et al.
Nature Chemical Biology|November 28, 2017
Inhibition of Delta-induced Notch signaling using fucose analogsMichael Schneider, Vivek Kumar, Lars Ulrik Nordstrøm, et al.
Nature Immunology|June 27, 2022
LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognitionQianqian Ming, Daiana P Celias, Chao Wu, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Engineering synthetic agonists for targeted activation of Notch signalingDavid H Perez, Daniel Antfolk, Xiomar E Bustos, et al.
Nature Chemical Biology|September 24, 2025
Engineering synthetic agonists for targeted activation of Notch signalingDavid H Perez, Daniel Antfolk, Shiun Chang, et al.
Nature Communications|August 29, 2024
Structural basis for mouse LAG3 interactions with the MHC class II molecule I-A<sup>b</sup>Qianqian Ming, Daniel Antfolk, David A Price, et al.
Nature Chemical Biology|September 1, 2022
Affinity-matured DLL4 ligands as broad-spectrum modulators of Notch signalingDavid Gonzalez-Perez, Satyajit Das, Daniel Antfolk, et al.
Journal of Virology|May 6, 2011
Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment stepMichelle C Sabo, Vincent C Luca, Jannick Prentoe, et al.
American Journal of Human Genetics|July 23, 2024
Functional characterization of 2,832 JAG1 variants supports reclassification for Alagille syndrome and improves guidance for clinical variant interpretationMelissa A Gilbert, Ernest Keefer-Jacques, Tanaya Jadhav, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|August 18, 2025
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma modelsManali S Phadke, Jiannong Li, Sathya Sriramareddy, et al.
Structure (London, England : 1993)|February 26, 2026
Structural basis for sialoglycan recognition by the immune inhibitory receptor Siglec-10Elliot Medina, Charlotte Mason, Timothy H Tran, et al.
Nature Chemical Biology|November 28, 2017
Inhibition of Delta-induced Notch signaling using fucose analogsMichael Schneider, Vivek Kumar, Lars Ulrik Nordstrøm, et al.
Nature Immunology|June 27, 2022
LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognitionQianqian Ming, Daiana P Celias, Chao Wu, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Engineering synthetic agonists for targeted activation of Notch signalingDavid H Perez, Daniel Antfolk, Xiomar E Bustos, et al.
Nature Chemical Biology|September 24, 2025
Engineering synthetic agonists for targeted activation of Notch signalingDavid H Perez, Daniel Antfolk, Shiun Chang, et al.
Nature Communications|August 29, 2024
Structural basis for mouse LAG3 interactions with the MHC class II molecule I-A<sup>b</sup>Qianqian Ming, Daniel Antfolk, David A Price, et al.
Nature Chemical Biology|September 1, 2022
Affinity-matured DLL4 ligands as broad-spectrum modulators of Notch signalingDavid Gonzalez-Perez, Satyajit Das, Daniel Antfolk, et al.
Journal of Virology|May 6, 2011
Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment stepMichelle C Sabo, Vincent C Luca, Jannick Prentoe, et al.
American Journal of Human Genetics|July 23, 2024
Functional characterization of 2,832 JAG1 variants supports reclassification for Alagille syndrome and improves guidance for clinical variant interpretationMelissa A Gilbert, Ernest Keefer-Jacques, Tanaya Jadhav, et al.
Pageof 4